glp-1 drug novo nordisk justifies reasoning behind failed Alzheimer's trials Details of failed studies cast
Description
doi: 10.1097/JCMA.0000000000001254, 4
The guidance has also been updated to include the 24-hour fluid diet recommendation
It could be quite distressing for patients who feel they have no control over impulsive behaviours. Encourage tapering and identify movement barriers When patients cease GLP-1 agonists, optimising medicines for comorbid health conditions could be beneficial, said Ms Feszczur
Conclusion Early findings suggest promising effects of GLP-1RAs on BEB
Effect of glucagon-like peptide-2 exposure on bone resorption: effectiveness of high concentration versus prolonged exposure
